Portal de Periódicos da CAPES

The Pathogenesis of Reactive Systemic Amyloidosis

1989; Wiley; Volume: 3; Issue: 1 Linguagem: Inglês

10.1111/j.1939-1676.1989.tb00326.x

1939-1676

Stephen P. DiBartola, Merrill D. Benson,

Trace Elements in Health

Journal of Veterinary Internal MedicineVolume 3, Issue 1 p. 31-41 Open Access The Pathogenesis of Reactive Systemic Amyloidosis Stephen P. DiBartola DVM, Stephen P. DiBartola DVM Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Ohio State University, Columbus, Ohio DVM, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Ohio State University, Columbus, OH 43210Search for more papers by this authorMerrill D. Benson MD, Merrill D. Benson MD Rheumatology Division, Richard L. Roudebush Veterans Administration Medical Center and the Department of Medicine, Indiana University School of Medicine, Indianapolis, IndianaSearch for more papers by this author Stephen P. DiBartola DVM, Stephen P. DiBartola DVM Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Ohio State University, Columbus, Ohio DVM, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Ohio State University, Columbus, OH 43210Search for more papers by this authorMerrill D. Benson MD, Merrill D. Benson MD Rheumatology Division, Richard L. Roudebush Veterans Administration Medical Center and the Department of Medicine, Indiana University School of Medicine, Indianapolis, IndianaSearch for more papers by this author First published: January 1989 https://doi.org/10.1111/j.1939-1676.1989.tb00326.xCitations: 33 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Franklin EC. Immunopathology of the amyloid diseases. Hosp Pract 1980; 15: 70– 77. 2 Glenner GG. Amyloid deposits and amyloidosis: The beta fibril- loses. N Engl J Med 1980; 302: 1283– 1292, 1333–1343. 3 Gorevic PD, Franklin EC. Amyloidosis. Annu Rev Med 1981; 32: 261– 271. 4 KJsilevsky R.. Amyloidosis: A familiar problem in the light of current pathogenetic developments. Lab Invest 1983; 49: 381– 390. 5 Husby G., Sletten K. Chemical and clinical classification of amyloidosis 1985. Scand J Immunol 1986; 23: 253– 265. 6 Buxbaum J. The amyloidoses: I. Biochemistry of the amyloid proteins. Lab Management 1987; 25: 38– 41. 7 Cohen AS, Connors LH. The pathogenesis and biochemistry of amyloidosis. J Pathol 1987; 151: 1– 10. 8 Westermark P., Johnson KH, Pitkanen P. Systemic amyloidosis: A review with emphasis on pathogenesis. Appl Pathol 1985; 3: 55– 68. 9 Puchtler H., Sweat F., Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem 1962; 10: 355– 364. 10 Glenner GG, Eanes ED, Page DL. The relation of the properties of Congo red-stained amyloid fibrils to the beta conformation. J Histochem Cytochem 1972; 20: 821– 826. 11 Cooper JH. Selective amyloid staining as a function of amyloid composition and structure: Histochemical analysis of the alkaline Congo red, standardized toluidine blue, and iodine methods. Lab Invest 1974; 31: 232– 238. 12 Glenner GG, Eanes ED, Bladen HA, et al. Beta pleated sheet fibrils: A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem 1974; 22: 1141 1158. 13 Wright JR, Calkins E., Humphrey RL. Potassium permanganate reaction in amyloidosis: A histologic method to assist in differentiating forms of this disease. Lab Invest 1977; 36: 274– 281. 14 Van Rijswijk MH, Van Heusden CWGJ. The potassium permanganate method: A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice. Am J Pathol 1979; 97: 43– 54. 15 Shirahama T., Skinner M., Cohen AS, et al. Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as beta-2 microglobulin. Lab Invest 1985; 53: 705– 709. 16 Glenner GG, Ignaczak TF, Page DL. The inherited systemic amyloidoses and localized amyloid deposits. In: JB Stanbury, JB Wyngaarden, DS Fredrickson, eds.. The Metabolic Basis of Inherited Disease. New York : McGraw-Hill, 1978; 1308– 1339. 17 Glenner GG, Ein D., Eanes DD, et al. Creation of amyloid fibrils from Bence Jones proteins in vitro. Science 1971; 174: 712– 714. 18 Glenner GG, Terry WD, Isersky C. Amyloidosis: Its nature and pathogenesis. Semin Hematol 1973; 10: 65– 86. 19 Glenner GG, Terry WD, Harada M., et al. Amyloid fibril proteins: Proof of homology with immunoglobulin light chains by sequence analysis. Science 1971; 172: 1150– 1151. 20 Solomon A., Frangione B., Franklin EC. Bence Jones proteins and light chains of immunoglobulins: Preferential association of the lambda VI subgroup of human light chains with amyloidosis AL (lambda). J Clin Invest 1982; 70: 453– 460. 21 Gertz MA, Skinner M., Cohen AS, et al. Isolation and characterization of a kappa amyloid fibril protein. Scand J Immunol 1985; 22: 245– 250. 22 Costa PP, Figueira AS, Bravo FR. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci USA 1978; 75: 4499– 4503. 23 Benson MD Partial amino acid sequence homology between an heredofamilial amyloid protein and human plasma prealbumin. J Clin Invest 1981; 67: 1035– 1041. 24 Cornwell GG, Westermark P., Natvig JB, et al. Senile cardiac amyloid: Evidence that fibrils contain a protein immunologically related to prealbumin. Immunology 1981; 44: 447– 452. 25 Gejyo F., Yamada T., Odani S., et al. A new form of amyloid protein associated with chronic hemodilaysis was identified as beta-2 microglobulin. Biochem Biophys Res Commun 1985; 129: 701– 706. 26 Connors LH, Shirahama T., Skinner M., et al. In vitro formation of amyloid fibrils from intact beta-2 microglobulin. Biochem Biophys Res Commun 1985; 131: 1063– 1068. 27 Grubb A., Jensson O., Gudmundson G., et al. Abnormal metabolism of gamma trace alkaline microprotein. N Engl J Med 1984; 311: 1547– 1549. 28 Ghiso J., Pons-Estel B., Frangione B. Hereditary cerebral amyloid angiopathy: The amyloid fibrils contain a protein which is a variant of cystatin C, an inhibitor of lysosomal cysteine proteases. Biochem Biophys Res Commun 1986; 136: 548– 554. 29 Glenner GG, Wong CW. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120: 885– 890. 30 Kang J., Lemaire HG, Untebeck A., et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature 1987; 325: 733– 736. 31 Kaye GC, Butler MG, D'Ardenne AJ, et al. Isolated atrial amyloid contains atrial natriuretic peptide: A report of six cases. Br Heart J 1986; 56: 317– 320. 32 Sletten K., Westermark P., Natvig JB. Characterization of amyloid proteins from medullary carcinoma of the thyroid. J Exp Med 1976; 143: 993– 998. 33 Kubota T., Kuroda E., Yamashima T., et al. Amyloid formation in prolactinoma. Arch Pathol Lab Med 1986; 110: 72– 75. 34 Mori H., Mori S., Saitoh Y., et al. Growth hormone-producing pituitary adenoma with crystal-like amyloid immunohisto-chemically positive for growth hormone. Cancer 1985; 55: 96– 102. 35 Westermark P., Wilander E. Islet amyloid in type 2 (noninsulindependent) diabetes is related to insulin. Diabetologia 1983; 24: 342– 346. 36 Johnson KH, Westermark P., Nilsson G., et al. Feline insular amyloid: Immunohistochemical and immunochemical evidence that the amyloid is insulin-related. Vet Pathol 1985; 22: 463– 468. 37 Westermark P., Wernstedt C., O'Brien TD, et al. Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 1987; 127: 414– 417. 38 Breathnach SM. Amyloid and amyloidosis. J Am Acad Dermatol 1988; 18: 1– 16. 39 Higuchi K., Matsumura A., Hashimoto K., et al. Isolation and characterization of senile amyloid-related antigenic substance (SASSAM) from mouse serum. J Exp Med 1983; 158: 1600– 1614. 40 Benson MD, Dwulet FE, DiBartola SP. Identification and characterization of amyloid protein AA in spontaneous canine amyloidosis. Lab Invest 1985; 52: 448– 452. 41 Westermark P., Johnson KH, Sletten K., et al. AA-amyloidosis in dogs: Partial amino acid sequence of protein AA and immunohistochemical cross-reactivity with human and cow AA-amyloid. Comp Biochem Physiol 1985; 82 211– 215. 42 DiBartola SP, Benson MD, Dwulet FE, et al. Isolation and characterization of amyloid protein AA in the Abyssinian cat. Lab Invest 1985; 52: 485– 489. 43 Westermark P., Johnson KH, Westermark GT, et al. Bovine amyloid protein AA: Isolation and amino acid sequence analysis. Comp Biochem Physiol 1986; 85B: 609– 614. 44 Sletten K., Husebekk A., Husby G. The amino acid sequence of an amyloid fibril protein AA isolated from the horse. Scand J Immunol 1987; 26: 79– 84. 45 Linke RP, Hoi PR, Gruys E., et al. Immunohistochemical identification and crossreactions of amyloid-A fibril protein in man and eleven other species. J Comp Pathol 1984; 94: 339– 356. 46 Levin M., Franklin EC, Frangione B., et al. The amino acid sequence of a major non-immunoglobulin component of some amyloid fibrils. J Clin Invest 1972; 51: 2773 2776. 47 Maury CPJ. Reactive (secondary) amyloidosis and its pathogenesis. Rheumatol Int 1984; 5: 1– 7. 48 Gorevic PD, Cleveland AB, Franklin EC. The biologic significance of amyloid. Ann NY Acad Sci 1982; 389: 380– 394. 49 Kushner I., Gewurz H., Benson MD. C-reactive protein and the acute phase response. J Lab Clin Med 1987 S7: 739– 749. 50 Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins-(pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34: 141– 212. 51 Lofberg H., Grubb A., Thysell H., et al. The prevalence of renal amyloidosis of the AA-type in a series of 1,158 consecutive autopsies. Acta Pathol Microbiol Immunol Scand 1987; 95A: 297– 302. 52 Bland JH. Clinical incidence of renal amyloidosis in rheumatoid arthritis. J Maine Med Assoc 1965; 56: 251– 254. 53 Slauson DO, Gribble DH, Russell SW. A clinicopathological study of renal amyloidosis in dogs, i Comp Pathol 1970; 80: 335– 343. 54 DiBartola SP, Tarr MJ, Parker AT, et al. Clinicopathologic findings in dogs with renal amyloidosis: 59 cases (1976 1986). J Am Vet Med Assoc (in press). 55 Cheville NF. Amyloidosis associated with cyclic neutropenia in the dog. Blood 1968; 31: 111– 114. 56 Gregory RS, Machado EA, Jones JB. Animal model: Amyloidosis associated with canine cyclic hematopoiesis in the gray Collie dog. Am J Pathol 1977; 87: 721– 724. 57 Albisser AM, McAdam KPWJ, Perlman K., et al. Unanticipated amyloidosis in dogs infused with insulin. Diabetes 1983; 32: 1092– 1101. 58 Bending JJ, Pickup JC, Rowe IF, et al. Continuous subcutaneous insulin infusion does not induce a significant acute phase response of serum amyloid A protein. Diabetologia 1985; 28: 113– 115. 59 Maxie MG. The urinary system. In: KVF Jubb, PC Kennedy, N. Palmer, eds.. Pathology of Domestic Animals. Orlando , FL : Academic Press, 1985; 368– 369. 60 Shaw DP, Gunson DE, Evans LH. Nasal amyloidosis in four horses. Vet Pathol 1987; 24: 183– 185. 61 Murray M., Rushton A., Selman I. Bovine renal amyloidosis: A clinicopathological study. Vet Rec 1972; 90: 210– 216. 62 Johnson R., Jamison K. Amyloidosis in six dairy cows. J Am Vet Med Assoc 1984; 185: 1538– 1543. 63 Winkelmann J., Veltmann E., Trautwein G., et al. Amyloidosis in chronic erysipelas polyarthritis in pigs. DTW 1979; 86: 131– 138. 64 Farnsworth GA, Miller S. An unusual form of hepatic amyloidosis in a goat. Vet Pathol 1985; 22: 184– 186. 65 Rings DM, Garry FB. Amyloidosis associated with paratuberculosis in a sheep. Comp Com Ed Pract Vet 1988; 10: 381– 385. 66 Lucke VM, Hunt VM. Interstitial nephropathy and papillary necrosis in the domestic cat. J Pathol Bacteriol 1965; 89: 723– 728. 67 Clark L., Seawright AA. Generalised amyloidosis in seven cats. Pathol Vet 1969; 6: 117– 134. 68 Chew DJ, DiBartola SP, Boyce JT, et al. Renal amyloidosis in related Abyssinian cats. J Am Vet Med Assoc 1982; 181: 139– 142. 69 Boyce JT, DiBartola SP, Chew DJ, et al. Familial renal amyloidosis in Abyssinian cats. Vet Pathol 1984; 21: 33– 38. 70 Cohen AS, Shirahama T. Animal model: Spontaneous and induced amyloidosis. Am J Pathol 1972; 68: 441– 444. 71 Skinner M., Shirahama T., Benson MD, et al. Murine amyloid protein AA in casein-induced experimental amyloidosis. Lab Invest 1977; 36: 420– 427. 72 Ho FCS, Fu KH. A new model of A Aamyloidosis induced by oral pristane in BALB/c mice. Br J Exp Pathol 1987; 68: 413– 420. 73 Sletten K., Husby G. The complete amino acid sequence of nonimmunoglobulin amyloid fibril protein AS in rheumatoid arthritis. Eur J Biochem 1974; 41: 117– 125. 74 Hermodson MA, Kuhn RW, Walsh KA, et al. Amino acid sequence of monkey amyloid protein A. Biochemistry 1972; 11: 2934– 2938. 75 Waalen K., Sletten K., Husby G., et al. The primary structure of amyloid fibril protein AA in endotoxininduced amyloidosis of the mink. Eur J Biochem 1980; 104: 407– 412. 76 Benson MD, DiBartola SP, Dwulet FE. A unique insertion in the primary structure of bovine amyloid AA protein. J Lab Clin Med (in press). 77 Brandwein SR, Skinner M., Cohen AS. Isolation and characterization of spontaneously occurring amyloid fibrils in aged Syrian (golden) hamsters. Fed Proc 1981; 40: 789. 78 Skinner M., Cathcart ES, Cohen AS, et al. Isolation and identification by sequence analysis of experimentally induced guinea pig amyloid fibrils. J Exp Med 1974; 140: 871– 876. 79 Eriksen N., Ericsson LH, Pearsall N., et al. Mouse amyloid protein A: Homology with nonimmunoglobulin protein of human and monkey amyloid substance. Proc Natl Acad Sci USA 1976; 73: 964– 967. 80 Dwulet FE, Benson MD. Primary structure of amyloid fibril protein AA in azocaseininduced amyloidosis in CBA/J mice. J Lab Clin Med 1987; 110: 322– 329. 81 Gorevic PD, Greenwald M., Frangione B., et al. The amino acid sequence of duck amyloid A (AA) protein. J Immunol 1977; 118: 1113– 1118. 82 Ericsson LH, Eriksen N., Walsh KA, et al. Primary structure of duck amyloid protein A: The form deposited in tissues may be identical to its serum precursor. FEBS Lett 1987; 218: 11– 16. 83 McAdam KPWJ, Li J., Knowles J., et al. The biology of SAA: Identification of the inducer, in vitro synthesis, and heterogeneity demonstrated with monoclonal antibodies. Ann NY Acad Sci 1982; 389: 126– 136. 84 Sipe JD, Ignaczak TF, Pollack PS, et al. Amyloid fibril protein AA: Purification and properties of the antigenically-related serum component as determined by solid phase radioimmunoassay. J Immunol 1976; 116: 1151– 1156. 85 Rosenthal CJ, Franklin EC, Frangione B., et al. Isolation and partial characterization of SAA: An amyloid-related protein from human serum. J Immunol 1976; 116: 1415– 1418. 86 Husebekk A., Skogen B., Husby G., et al. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol 1985; 21: 283– 287. 87 Baltz ML, Rowe IF, Caspi D., et al. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils Clin Exp Immunol 1986; 66: 701– 708. 88 Husebekk A., Skogen B., Husby G. Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoprotein (HDL). Scand J Immunol 1987; 25: 375– 381. 89 Benditt EP, Hoffman JS, Eriksen N. SAA, an apoprotein of HDL: Its structure and function. Ann NY Acad Sci 1982; 389: 183– 189. 90 Benson MD, Cohen AS. Serum amyloid A protein in amyloidosis, rheumatic, and neoplastic diseases. Arthritis Rheum 1979; 22: 36– 42. 91 Raynes JG, Cooper EH. Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease. J Clin Pathol 1983; 36: 798– 803. 92 Eriksen N., Benditt EP. Trauma, high density lipoproteins, and serum amyloid protein A. Clin Chim Acta 1984; 140: 139– 149. 93 Maury CPJ. Comparative study of serum amyloid A protein and C-reactive protein in disease. Clin Sci 1985; 68: 233– 238. 94 Biran H., Friedman N., Neumann L., et al. Serum amyloid A (SAA) variations in patients with cancer: Correlation with disease activity, stage, primary site, and prognosis. J Clin Pathol 1986; 39: 794– 797. 95 Shainkin-Kestenbaum R., WinikoffY, Cristal N. Serum amyloid A concentrations during the course of acute ischaemic heart disease. J Clin Pathol 1986; 39: 635– 637. 96 Sipe JD, Vogel SN, Sztein MB, et al. The role of interleukin-1 in acute phase serum amyloid A (SAA) and serum amyloid P (SAP) biosynthesis. Ann NY Acad Sci 1982; 389: 137– 150. 97 Benson MD, Scheinberg MA, Shirahama T., et al. Kinetics of serum amyloid protein A in casein-induced murine amyloidosis. J Clin Invest 1977; 59: 412– 417. 98 Maury CPJ, Teppo AM, Eklund B., et al. Serum amyloid A protein: A sensitive indicator of renal allograft rejection in humans. Transplantation 1983; 36: 501– 504. 99 Maury CPJ, Hockerstedt K., Teppo AM, et al. Changes in serum amyloid A protein and beta-2 microglobulin in association with liver allograft rejection. Transplantation 1984; 38: 552– 554. 100 Sipe JD, Vogel SN, Ryan JL, et al. Detection of a mediator derived from endotoxinstimulated macrophages that induces the acute phase serum amyloid A response in mice. J Exp Med 1979; 150: 597– 606. 101 Benson MD, Kleiner E. Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein. J Immunol 1980; 124: 495– 499. 102 Benson MD. In vitro synthesis of the acute phase reactant SAA by hepatocytes. Ann NY Acad Sci 1982; 389: 116– 120. 103 Tatsuta E., Shirahama T., Sipe JD, et al. Kinetics of SAP and SAA production by cultured mouse liver cells. Ann NY Acad Sci 1982; 389: 467– 470. 104 Hoffman JS, Benditt EP. Secretion of serum amyloid protein and assembly of serum amyloid protein-rich high density lipoprotein in primary mouse hepatocyte culture. J Biol Chem 1982; 257: 10518– 10522. 105 Sipe JD, Colten HR, Goldberger G., et al. Human serum amyloid A (SAA): Biosynthesis and postsynthetic processing of pre SAA and structural variants defined by complementary DNA. Biochemistry 1985; 24: 2931– 2936. 106 Shirahama T., Skinner M., Cohen AS. Heterogenous participation of the hepatocyte population in amyloid protein AA synthesis. Cell Biol Int Rep 1984; 8: 849– 856. 107 Shirahama T., Cohen AS. Immunocytochemical study of hepatocyte synthesis of amyloid AA. Am J Pathol 1985; 118: 108– 115. 108 Miura K., Takahashi Y., Shirasawa H. Immunohistochemical detection of serum amyloid A protein in the liver and the kidney after casein injection. Lab Invest 1985; 53: 453– 463. 109 Takahasi M., Yokota T., Yamashita Y., et al. Ultrastructural evidence for the synthesis of serum amyloid A protein by murine hepatocytes. Lab Invest 1985; 52: 220– 223. 110 Coetzee GA, Strachan AF, van der Westhuyzen DR, et al. Serum amyloid A-containing human high density lipoprotein 3. J Biol Chem 1986; 261: 9644– 9651. 111 Parks JS, Rudel LL. Alteration of high density lipoprotein subfraction distribution with induction of serum amyloid A protein (SAA) in the nonhuman primate. J Lipid Res 1985; 26: 82– 91. 112 Hoffman JS, Benditt EP. Changes in high density lipoprotein content following endotoxin administration in the mouse. J Biol Chem 1982; 257: 10510– 10517. 113 Lowell CA, Stearman RS, Morrow JF. Transcriptional regulation of serum amyloid A gene expression. J Biol Chem 1986; 261: 8453– 8461. 114 Lowell CA, Potter DA, Stearman RS, et al. Structure of the murine serum amyloid A gene family. J Biol Chem 1986; 261: 8442– 8452. 115 Yamamoto KI, Goto N., Kosaka J., et al. Structural diversity of murine serum amyloid A genes: Evolutionary implications. J Immunol 1987; 139: 1683– 1688. 116 Bausserman LL, Herbert PN, McAdam KPWJ. Serum amyloid A polymorphism in a subject with a naturally occurring inflammatory response. Clin Chim Acta 1982; 118: 201– 207. 117 Bausserman LL, Saritelli AL, Herbert PN, et al. NH2-terminal analysis of four of the polymorphic forms of human serum amyloid A proteins. Biochim Biophys Acta 1982; 704: 556– 559. 118 Kluve-Beckerman B., Naylor SL, Marshall A., et al. Localization of human SAA gene(s) to chromosome 11 and detection of DNA polymorphisms. Biochem Biophys Res Commun 1986; 137: 1196– 1204. 119 Kluve-Beckerman B., Long GL, Benson MD. DNA sequence evidence for polymorphic forms of human serum amyloid A (SAA). Biochem Genet 1986; 24: 795– 803. 120 Maury CPJ, Ehnholm C., Lukka M. Serum amyloid A protein (SAA) subtypes in acute and chronic inflammation. Ann Rheum Dis 1985; 44: 711– 715. 121 Ramadori G., Sipe JD, Colten HR. Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites. J Immunol 1985; 135: 3645– 3647. 122 Meek RL, Benditt EP. Amyloid A gene family expression in different mouse tissues. J Exp Med 1986; 164: 2006– 2017. 123 Fuks A., Zucker-Franklin D. Impaired Kupffer cell function pre- cedes development of secondary amyloidosis. J Exp Med 1985; 161: 1013– 1028. 124 Bausserman LL, Saritelli AL, Van Zuiden P., et al. Degradation of serum amyloid A by isolated perfused rat liver. J Biol Chem x 1987; 262: 1583– 1589. 125 Baltz ML, Rowe IF, Caspi D., et al. Acute phase high density lipoprotein in the rat does not contain serum amyloid A protein. Biochem J 1987; 242: 301– 303. 126 Hoffman JS, Benditt EP. Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (ApoSAA), in the mouse. J Clin Invest 1983; 71: 926– 934. 127 Benson MD, Aldo-Benson M. Effect of purified protein SAA on immune response in vitro: Mechanisms of suppression. J Immunol 1979; 122: 2077– 2082. 128 Aldo-Benson M., Benson MD. SAA suppression of immune response in vitro: Evidence of an effect on T cell-macrophage interaction. J Immunol 1982; 128: 2390– 2393. 129 Kaminski NE, Holsapple MP. Inhibition of macrophage accessory cell function in casein-treated B6C3F, mice. J Immunol 1987; 139: 1804– 1810. 130 Kisilevsky R., Boudreau L., Foster D. Kinetics of amyloid deposition: II. The effects of dimethylsulfoxide and colchicine therapy. Lab Invest 1983; 48: 60– 77. 131 Zemer D., Pras M., Sohar E., et al. Colchicine in the prevention and treatment of amyloidosis of familial Mediterranean fever. N Engl J Med 1986; 314: 1001– 1005. 132 Brandwein SR, Sipe JD, Skinner M., et al. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Lab Invest 1985; 52: 319– 325. 133 Axelrad MA, Kisilevsky R., Willmer J., et al. Further characterization of amyloid-enhancing factor. Lab Invest 1982; 47: 139– 146. 134 Kisilevsky R., Boudreau L. Kinetics of amyloid deposition: I. The effects of AEF and splenectomy. Lab Invest 1983; 48: 53– 59. 135 Niewold TA, Hoi PR, Van Andel ACJ, et al. Enhancement of amyloid induction by amyloid fibril fragments in hamster. Lab Invest 1987; 56: 544– 549. 136 Ravid M., Shapira J., Lang R., et al. Prolonged dimethylsulfoxide treatment of 13 patients with systemic amyloidosis. Ann Rheum Dis 1982; 41: 587– 592. 137 Kedar I., Greenwald M., Ravid M. Treatment of experimental murine amyloidosis with dimethylsulfoxide. Eur J Clin Invest 1977; 7: 149– 150. 138 Greenwald M., Kedar I., Sohar E. The effect of colchicine and dimethylsulfoxide (DMSO) on the genetic amyloidosis of the white Pekin duck. In: GG Glenner, PP Costa, F. Freitas, eds. Amyloid and Amyloidosis. Amsterdam : Excerpta Medica, 1980; 584– 586. 139 Spyridakis L., Brown S., Barsanti J., et al. Amyloidosis in a dog: Treatment with dimethylsulfoxide. J Am Vet Med Assoc 1986; 189: 690– 691. 140 Gruys E., Sijens RJ, Biewenga WJ. Dubious effect of dimethylsulfoxide (DMSO) therapy on amyloid deposits and amyloidosis. Vet Res Comm 1981; 5: 21– 32. 141 Van Rijswijk MH, Ruinen L., Donker AJM, et al. Dimethylsulfoxide in the treatment of AA amyloidosis. Ann NY Acad Sci 1983; 389: 67– 83. 142 Ravid M., Chen B., Berheim J., et al. Ascorbic acid induced regression of amyloidosis in experimental animals. Br J Exp Pathol 1985; 66: 137– 141. 143 Baltz ML, Caspi D., Glatthaar B., et al. The failure of ascorbic acid to alter the induction or remission of murine amyloidosis. Clin Exp Immunol 1984; 57: 657– 662. 144 Baltz ML, Pepys MB, Moser U., et al. Effect of vitamin C dietary supplementation on survival in amyloidosis. Arthritis Rheum 1987; 30: 718– 719. 145 Woo P., O'Brien J., Robson M., et al. A genetic marker for systemic amyloidosis in juvenile arthritis. Lancet 1987; 2 (8562): 767– 769. 146 Snow AD, Willmer J., Kisilevsky R. Sulfated glycosaminpglycans: A common constituent of all amyloids Lab Invest 1987; 56: 120– 123. 147 Snow AD, Kisilevsky R. Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis: A histochemical study. Lab Invest 1985; 53: 37– 44. 148 Snow AD, Kisilevsky R., Stephens C., et al. Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Lab Invest 1987; 56: 665– 675. 149 Linker A., Carney HC. Presence and role of glycosaminoglycans in amyloidosis. Lab Invest 1987; 57: 297– 305. 150 Falck HM, Maury CPJ, Teppo AM, et al. Correlation of persistently high serum amyloid A protein and C-reactive protein concentrations with rapid progression of secondary amyloidosis. Br Med J 1983; 286: 1373– 1456. 151 Hoffman JS, Ericsson LH, Eriksen N., et al. Murine tissue amyloid protein AA: NH2-terminal sequence identity with only one of two serum amyloid protein (apoSAA) gene products. J Exp Med 1984; 159: 641– 646. 152 Yamamoto KI, Migita S. Complete primary structures of two major murine serum amyloid A proteins deduced from cDNA sequences. Proc Natl Acad Sci USA 1985; 82: 2915– 2919. 153 Meek RL, Hoffman JS, Benditt EP. Amyloidogenesis: One serum amyloid A isotype is selectively removed from the circulation. J Exp Med 1986; 163: 499– 510. 154 Yamamoto KI, Shiroo M., Migita S. Diverse gene expression for isotypes of murine serum amyloid A protein during acute phase reaction. Science 1986; 232: 227– 229. 155 Lavie G., Zucker-Franklin D., Franklin EC. Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes. J Exp Med 1978; 148: 1020– 1031. 156 Lavie G., Zucker-Franklin D., Franklin EC. Elastase-like proteases on the surface of human blood monocytes: Possible role in amyloid formation. J Immunol 1980; 125: 175– 180. 157 Skinner M., Schneller SI, Connors LH, et al. Observations on the amyloid-degrading activity of serum and its relationship to human neutrophil elastase. Trans Assoc Am Physicians 1983; 96: 437– 443. 158 Skinner M., Stone P., Shirahama T., et al. The association of an elastase with amyloid fibrils. Proc Soc Exp Biol Med 1986; 181: 211– 214. 159 Teppo AM, Maury CPJ, Wegelius O. Characteristics of the amyloid A fibril-degrading activity of human serum. Scand J Immunol 1982; 16: 309– 314. 160 Teppo AM, Maury CPJ. Do serine proteases degrade amyloid fibrils Scand J Immunol 1983; 18: 363– 366. 161 Bausserman LL, Herbert PN. Degradation of serum amyloid A and apolipoproteins by serum proteases. Biochemistry 1984; 23: 2241– 2245. 162 Maury CPJ, Teppo AM. Mechanism of reduced amyloid-A-degrading activity of serum of patients with secondary amyloidosis. Lancet 1982; 2 (8292): 234– 237. 163 Scott DL, Bracken P., Bacon PA, et al. Amyloid degrading factor activity: A non-specific calcium-mediated effect. Clin Sci 1985; 68: 333– 339. 164 Caspni D., Baltz ML, Feinstein A., et al. Does serum degrade amyloid fibrils? Failure to confirm enzymatic degradation of amyloid A fibrils as the basis of the so-called "amyloid degrading activity" of serum. In: GG Glenner, EF Osserman, EP Benditt, et al., eds. Amyloidosis. New York : Plenum, 1986; 279– 284. 165 Benson MD. Pathogenesis of amyloidosis. In: DJ Chew, SP DiBartola, eds. Seventh Annual Kal Kan Symposium for the Treatment of Small Animal Diseases. Vernon : Kal Kan Foods, 1984; 47– 52. 166 DiBartola SP, Tarr MJ. Corticotropin and thyrotropin response tests in Abyssinian cats with familial amyloidosis. J Am Anim Hosp Assoc 1988 (in press). 167 DiBartola SP, Tarr MJ, Benson MD. Tissue distribution of amyloid deposits in Abyssinian cats with familial amyloidosis. J Comp Pathol 1986; 96: 387– 398. 168 Blanchard JL, Baskin GB, Watson EA. Generalized amyloidosis in Rhesus monkeys. Vet Pathol 1986; 23: 425– 430. 169 Shirahama T., Cohen AS. Ultrastructural studies of renal peritubular amyloid experimentally-induced in guinea pigs. Lab Invest 1968; 19: 122– 131. 170 Hinton M., Lucke VM. Histological findings in amyloidosis of rabbits. J Comp Pathol 1982; 92: 285– 294. 171 Hinton M., Lucke VM. Ultrastructural findings of the kidney in amyloidosis of rabbits. J Comp Pathol 1982; 92: 295– 300. 172 Westermark P., Sletten K., Eriksson M. Morphologic and chemical variation of the kidney lesions in amyloidosis secondary to rheumatoid arthritis. Lab Invest 1979; 41: 427– 431. 173 Westermark GT, Westermark P., Sletten K. Amyloid fibril protein AA: Characterization of uncommon subspecies from a patient with rheumatoid arthritis. Lab Invest 1987; 57: 57– 64. Citing Literature Volume3, Issue1January 1989Pages 31-41 ReferencesRelatedInformation